Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Staging
400 results:
1. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
[TBL] [Abstract] [Full Text] [Related]
2. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
[TBL] [Abstract] [Full Text] [Related]
3. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract] [Full Text] [Related]
4. [
Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
[TBL] [Abstract] [Full Text] [Related]
5. Bone marrow metastasis in nonhematological malignancies: A study from tertiary care center.
Singh A; Rawat S; Kushwaha R; Jain M; Verma SP; Verma N; Singh US
Ann Afr Med; 2024; 23(1):91-99. PubMed ID: 38358178
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
7. Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic prostate cancer: Comparative Analysis in Terms of CRPC-M0 Progression.
Salciccia S; Frisenda M; Tufano A; Di Pierro G; Bevilacqua G; Rosati D; Gobbi L; Basile G; Moriconi M; Mariotti G; Forte F; Carbone A; Pastore A; Cattarino S; Sciarra A; Gentilucci A
Clin Genitourin Cancer; 2024 Apr; 22(2):74-83. PubMed ID: 37758559
[TBL] [Abstract] [Full Text] [Related]
8. 18 F-prostate specific membrane antigen positron emission tomography/computerized tomography for lymph node staging in medium/high risk prostate cancer: A systematic review and meta-analysis.
Lv Z; Song L; Wang M; Hou H; Li H; Wang X; Wang J; Wang J; Liu M
Chin Med J (Engl); 2024 Apr; 137(8):949-958. PubMed ID: 37690993
[TBL] [Abstract] [Full Text] [Related]
9. Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G; Garlatti P; Di Cataldo V; Triggiani L; Simoni N; Detti B; Lorenzetti V; Colombo F; Morelli V; Ganovelli M; Caprara L; Orsatti C; Burchini L; Frosini G; Bertini N; Loi M; Simontacchi G; Greto D; Desideri I; Meattini I; Livi L
Radiol Med; 2023 Nov; 128(11):1423-1428. PubMed ID: 37597125
[TBL] [Abstract] [Full Text] [Related]
10. The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples.
Feitosa PMFA; Hirth CG; Silva-Fernandes IJL; Dornelas CA
APMIS; 2023 Sep; 131(9):465-471. PubMed ID: 37439391
[TBL] [Abstract] [Full Text] [Related]
11. Targeted Biopsy in Men High Risk for prostate cancer:
Pepe P; Pennisi M
Clin Genitourin Cancer; 2023 Dec; 21(6):639-642. PubMed ID: 37394379
[TBL] [Abstract] [Full Text] [Related]
12. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract] [Full Text] [Related]
13. staging prostate cancer with
Kesler M; Cohen D; Levine C; Sarid D; Keizman D; Yossepowitch O; Even-Sapir E
J Nucl Med; 2023 Jul; 64(7):1030-1035. PubMed ID: 37116912
[TBL] [Abstract] [Full Text] [Related]
14.
Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
In Vivo; 2023; 37(3):1318-1322. PubMed ID: 37103095
[TBL] [Abstract] [Full Text] [Related]
15. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
[TBL] [Abstract] [Full Text] [Related]
16. Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial.
Chang Y; Zhao X; Xiao Y; Yan S; Xu W; Wang Y; Zhang H; Ren S
Front Med; 2023 Apr; 17(2):231-239. PubMed ID: 36580231
[TBL] [Abstract] [Full Text] [Related]
17.
Haidar M; Abi-Ghanem AS; Moukaddam H; Jebai ME; Al Zakleet S; Al Rayess S; Akkawi AR; Kassas M; Tamim H; Hajj AE; Estrada-Lobato E; Osman MM; Shamseddine A
Sci Rep; 2022 Nov; 12(1):20500. PubMed ID: 36443430
[TBL] [Abstract] [Full Text] [Related]
18. Role of
Sopeña Sutil R; Gómez Grande A; González Díaz A; Téigel Tobar J; Cabeza Rodríguez MÁ; González Billalabeitia E; Rodríguez Antolín A
Arch Esp Urol; 2022 Oct; 75(8):684-692. PubMed ID: 36330569
[TBL] [Abstract] [Full Text] [Related]
19. Fluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy.
Özkan A; Köseoğlu E; Canda AE; Çil BE; Aykanat İC; Sarıkaya AF; Tarım K; Armutlu A; Kulaç İ; Barçın E; Falay FO; Kordan Y; Baydar DE; Balbay MD; Esen T
J Robot Surg; 2023 Jun; 17(3):885-890. PubMed ID: 36329287
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of 18 F-PSMA-1007 PET/CT With 68 Ga-PSMA-11 PET/CT for Initial staging in Intermediate- and High-Risk prostate cancer.
Chandekar KR; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
Clin Nucl Med; 2023 Jan; 48(1):e1-e8. PubMed ID: 36240786
[TBL] [Abstract] [Full Text] [Related]
[Next]